About BioMedPartners
Investments are directed by BioMedPartners toward early to mid-stage companies in the life sciences sector, including diagnostics, biopharma, medical devices, and biotech. Operations center on European geographies, with typical commitments ranging from CHF2 million to CHF10 million per company. Assets under management total CHF320 million. Notable portfolio inclusions encompass Effector Therapeutics, Amplyx Pharmaceuticals, NanoString Technologies, and Affimed Therapeutics. The firm is based in Basel, Switzerland.
- Headquarter Basel, Switzerland
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BioMedPartners
Unlock access to complete
Unlock access to complete
Funding Insights of BioMedPartners
Detailed funding history for BioMedPartners
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioMedPartners
Investment portfolio details for BioMedPartners
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioMedPartners
Detailed financials for BioMedPartners
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomedpartners Comparisons
Peer comparison for BioMedPartners
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioMedPartners
Detailed competitors of BioMedPartners
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomedpartners
Complete news archive for BioMedPartners
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioMedPartners
BioMedPartners is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Investments are directed by BioMedPartners toward early to mid-stage companies in the life sciences sector, including diagnostics, biopharma, medical devices, and biotech. Operations center on European geographies, with typical commitments ranging from CHF2 million to CHF10 million per company. Assets under management total CHF320 million. Notable portfolio inclusions encompass Effector Therapeutics, Amplyx Pharmaceuticals, NanoString Technologies, and Affimed Therapeutics. The firm is based in Basel, Switzerland.